Therefore, as previously proposed and consistent with our results, differences in sIgE levels or IgE-binding peptides are not correlated to the clinical phenotype of patients with peanut allergy, while the blocking IgG4 antibodies could provide an additional explanation for the absence of clinical reactivity (32). The gene discussed is IGHE; the disease is peanut allergic reaction.